JYOTHYLABNSEJyothy Labs Limited· Personal CareMinimalNeutral
Announced Tue, 5 May · 13:37 IST

Jyothy Labs Limited has informed the Exchange about Copy of Newspaper Publication for Financial Results

JYOTHYLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹264.95
prior close
₹263.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.2+0.1-0.2-2.6-1.9-1.5-10.9-13.9-16.8-22.6-24.4-28.1
Up moveDown movePending
AI summary

Jyothy Labs reported total income from operations of ₹71,741 lakhs for Q4 FY26 (vs ₹66,596 lakhs in Q4 FY25) and ₹2,94,429 lakhs for full year FY26 (vs ₹2,84,392 lakhs in FY25), showing modest revenue growth. However, net profit after tax declined to ₹6,752 lakhs in Q4 FY26 (vs ₹7,700 lakhs in Q4 FY25) and ₹33,319 lakhs for FY26 (vs ₹37,117 lakhs in FY25). EPS fell from ₹10.11 in FY25 to ₹9.07 in FY26. The board has recommended a final dividend of ₹3.50 per share of ₹1 face value, subject to shareholder approval. Key notes include the sale of the Bangladesh subsidiary (JKBL) in March 2025 for ₹210 lakhs, resulting in a ₹370 lakh exceptional loss, and the impact of new Indian labour codes effective November 2025 (impact not material). The company now reports standalone results only after divesting its only subsidiary.

Likely market impact

Revenue grew modestly but profit declined year-on-year, indicating margin pressure. The dividend of ₹3.50 per share offers shareholder returns. The stock may see neutral-to-mild negative reaction given the profit decline despite flat revenue growth.